Back to results
US 2025/0084086 A1Published application
Process for preparing btk inhibitors
AssigneeHoffmann-La Roche Inc.
InventorsStephan BACHMANN, Lukas CHYTIL, Serena Maria FANTASIA, Alec FETTES, Ursula HOFFMANN
Life of this patent
Estimating the term…
Abstract
Methods for preparing the Bruton's Tyrosine Kinase (“BTK”) inhibitor compound 2-{3′-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4′]bipyridinyl-2′-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one are provided.
Claims13
1-29. (canceled)
A method of preparing compound 141, or a salt thereof, the method comprising:
- (a) forming a first reaction mixture comprising compound 140, a catalyst, a solvent, and hydrogen, wherein the first reaction mixture catalyst is selected from the group consisting of Ra—Ni, Ra—Co, Pt/V@C, Co@Chitin, Ni-phen@SiO2, and Ni-phen@TiO2;
- and
- (b) reacting the first reaction mixture to form a first reaction product mixture comprising compound 141 according to the following scheme:
- wherein the yield of compound 141 based on compound 140 is at least 95%.
1 more element
Dependencies are inferred from the claim text.